This startup develops and commercializes biomedical diagnostic tools, including PCR testing kits and nucleic acid extraction, for various diseases. They partner with university research teams and commercial entities to translate scientific discoveries into diagnostic products and solutions.
Funding
Funding not disclosed
Founders
Product
Problem
Current diagnostic methods for various diseases often require specialized equipment and can be time-consuming, limiting accessibility and delaying results. This can hinder timely diagnosis and treatment decisions.
Solution
GeneSpector Innovations is a biotech company that develops and commercializes a range of diagnostic tools and kits to address these challenges. They focus on translating scientific discoveries into practical diagnostic solutions through internal R&D, partnerships with academic institutions, and collaborations with commercial entities. Their portfolio includes solutions for sample collection, nucleic acid extraction, PCR-based detection of respiratory pathogens, prediction of pregnancy-related complications, NGS diagnostics for multiple myeloma, severity prediction for respiratory infections, ELISA-based diagnostics for hereditary kidney diseases, MALDI plates for mass spectrometry, and lab-on-card technology. These solutions aim to provide faster, more accurate, and more accessible diagnostic information.
Target Audience
The primary target audience includes clinical laboratories, hospitals, research institutions, and diagnostic companies seeking innovative and efficient diagnostic solutions.
Features
- viRNAtrap™ CE-IVDR Extraction Kit: A magnetic bead-based kit for rapid manual or automated nucleic acid extraction, compatible with open platforms.
- PCR kits for COVID-19 and other respiratory diseases: CE-IVD certified kits for rapid detection using one-step RT-qPCR with fluorescently labeled probes and proprietary GEMINI™ probe technology.
- Pregnancy-Related Complications Diagnostics: A method for predicting pregnancy complications from a blood sample as early as the 10th week of pregnancy, with high success rates for preeclampsia, fetal growth restriction, preterm birth, and gestational hypertension.
- Human NGS Diagnostics: Next-generation sequencing solutions for various diagnostic applications, including a kit for diagnosing multiple myeloma using a custom set of oligonucleotides and bioinformatics analysis.
- Severity Predictor of Respiratory Infections: A PCR-based diagnostic method using nasopharyngeal swabs to predict the severity of infectious disease symptoms days in advance.
- ELISA-based Diagnostics of Hereditary Kidney Diseases: A cost-effective ELISA method to detect the MUC1 protein in blood plasma for screening and monitoring Autosomal Dominant Tubulo-Interstitial Kidney Disease (ADTKD).
- MALDI Plates for Mass Spectrometry: 3D-printed single-use sample target plates for Microbe MALDI Biotyping, offering a cost-effective alternative to traditional equipment.
- Lab-on-Card Technology: A microfluidic card for sample work-up, analyte detection, and result visualization, suitable for point-of-care diagnostics.
- viRNAtrap™ Collection Tubes: Unique DNA/RNA transport and storage medium that immediately inactivates viruses, preserving genetic integrity of samples at ambient temperature.